{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T03:27:24Z","timestamp":1791170844446,"version":"4.1.0"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,6,17]],"date-time":"2013-06-17T00:00:00Z","timestamp":1371427200000},"content-version":"vor","delay-in-days":16,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"crossref","award":["IBN-Net #01.06.0842-00"],"award-info":[{"award-number":["IBN-Net #01.06.0842-00"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Programa de Apoio aos N\u00facleos de Excel\u00eancia"},{"name":"Funda\u00e7\u00e3o de Apoio \u00e0 Pesquisa do Estado de Santa Catarina"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.brainres.2013.03.029","type":"journal-article","created":{"date-parts":[[2013,3,30]],"date-time":"2013-03-30T09:01:05Z","timestamp":1364634065000},"page":"103-116","source":"Crossref","is-referenced-by-count":60,"special_numbering":"C","title":["Atorvastatin improves cognitive, emotional and motor impairments induced by intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration in rats, an experimental model of Parkinson's disease"],"prefix":"10.1016","volume":"1513","author":[{"given":"Adalberto A.","family":"Castro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e1rbara P.","family":"Wiemes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filipe C.","family":"Matheus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda R.","family":"Lapa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giordano G.","family":"Viola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adair R.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla I.","family":"Tasca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui D.","family":"Prediger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainres.2013.03.029_bib1","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2165\/00002018-200831050-00004","article-title":"Use of statins and the risk of Parkinson's disease: a retrospective case-control study in the UK","volume":"31","author":"Becker","year":"2008","journal-title":"Drug Saf."},{"key":"10.1016\/j.brainres.2013.03.029_bib2","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1517\/14740330902859956","article-title":"Statins and the risk of Parkinson disease: an update on the controversy","volume":"8","author":"Becker","year":"2009","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.brainres.2013.03.029_bib3","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1006\/exnr.1997.6648","article-title":"Effects of different schedules of MPTP administration on dopaminergic neurodegeneration in mice","volume":"148","author":"Bezard","year":"1997","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.brainres.2013.03.029_bib4","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1007\/s00702-004-0168-1","article-title":"Cognitive dysfunction and dementia in Parkinson's disease","volume":"111","author":"Bosboom","year":"2004","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.brainres.2013.03.029_bib5","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.brainres.2013.03.029_bib6","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.bbr.2012.01.016","article-title":"Lithium and valproate prevent olfactory discrimination and short-term memory impairments in the intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) rat model of Parkinson's disease","volume":"229","author":"Castro","year":"2012","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainres.2013.03.029_bib7","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0079-6123(10)84017-8","article-title":"The challenge of non-motor symptoms in Parkinson's disease","volume":"184","author":"Chaudhuri","year":"2010","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.brainres.2013.03.029_bib8","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1023\/A:1020736131907","article-title":"The lesion of the rat substantia nigra pars compacta dopaminergic neurons as a model for Parkinson's disease memory disabilities","volume":"22","author":"Da Cunha","year":"2002","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.brainres.2013.03.029_bib9","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/BF00518192","article-title":"Modulation of social memory in male rats by neurohypophyseal peptides","volume":"91","author":"Dantzer","year":"1987","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.brainres.2013.03.029_bib10","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","article-title":"Epidemiology of Parkinson's disease","volume":"5","author":"De Lau","year":"2006","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.brainres.2013.03.029_bib11","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/PL00007725","article-title":"Cognitive deficits in Parkinson's disease","volume":"244","author":"Dubois","year":"1997","journal-title":"J. Neurol."},{"key":"10.1016\/j.brainres.2013.03.029_bib12","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1111\/j.1476-5381.2011.01426.x","article-title":"Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease","volume":"164","author":"Duty","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.brainres.2013.03.029_bib13","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0006-8993(03)03198-6","article-title":"Failure of estrogen to protect the substantia nigra pars compacta of female rats from lesion induced by 6-hydroxydopamine","volume":"986","author":"Ferraz","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2013.03.029_bib14","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1001\/archneurol.2011.1060","article-title":"Prospective study of statin use and risk of Parkinson disease","volume":"69","author":"Gao","year":"2012","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.brainres.2013.03.029_bib15","doi-asserted-by":"crossref","first-page":"13543","DOI":"10.1523\/JNEUROSCI.4144-09.2009","article-title":"Simvastatin inhibits the activation of p21ras and prevents the loss of dopaminergic neurons in a mouse model of Parkinson's disease","volume":"29","author":"Ghosh","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2013.03.029_bib16","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1471-4159.2007.05148.x","article-title":"Simvastatin prevents the inflammatory process and the dopaminergic degeneration induced by the intranigral injection of lipopolysaccharide","volume":"105","author":"Hern\u00e1ndez-Romero","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2013.03.029_bib17","doi-asserted-by":"crossref","first-page":"c2197","DOI":"10.1136\/bmj.c2197","article-title":"Unintended effects of statins in men and women in England and Wales: population based cohort study using the Qresearch database","volume":"340","author":"Hippisley-Cox","year":"2010","journal-title":"Br. Med. J."},{"key":"10.1016\/j.brainres.2013.03.029_bib18","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/334345a0","article-title":"Melanized dopamine neurons are differentially susceptible to degeneration in Parkinson's disease","volume":"334","author":"Hirsch","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.brainres.2013.03.029_bib19","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S1474-4422(09)70062-6","article-title":"Neuroinflammation in Parkinson's disease: a target for neuroprotection?","volume":"8","author":"Hirsch","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.brainres.2013.03.029_bib20","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.bbr.2011.12.035","article-title":"Effects of MK-801 on recognition and neurodegeneration in an MPTP-induced Parkinson's rat model","volume":"229","author":"Hsieh","year":"2012","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainres.2013.03.029_bib21","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/mds.21290","article-title":"Lower low-density lipoprotein cholesterol levels are associated with Parkinson's disease","volume":"22","author":"Huang","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.brainres.2013.03.029_bib22","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/S0140-6736(00)03155-X","article-title":"Statins and the risk of dementia","volume":"356","author":"Jick","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.brainres.2013.03.029_bib23","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.brainres.2006.12.011","article-title":"Lipid-lowering drugs in the MPTP mouse model of Parkinson's disease: fenofibrate has a neuroprotective effect, whereas bezafibrate and HMG-CoA reductase inhibitors do not","volume":"1135","author":"Kreisler","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2013.03.029_bib24","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.brainres.2012.06.050","article-title":"Neuroprotective potential of atorvastatin and simvastatin (HMG-CoA reductase inhibitors) against 6-hydroxydopamine (6-OHDA) induced Parkinson-like symptoms","volume":"1471","author":"Kumar","year":"2012","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2013.03.029_bib25","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/70978","article-title":"Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease","volume":"5","author":"Liberatore","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.brainres.2013.03.029_bib26","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0006-8993(02)03222-5","article-title":"Nerve growth factor levels in Parkinson disease and experimental parkinsonian rats","volume":"952","author":"Lorigados Pedre","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2013.03.029_bib27","doi-asserted-by":"crossref","unstructured":"Ludka, F.K., Zomkowski, A.D., Cunha, M.P., Dal-Cim, T., Zeni, A.L., Rodrigues, A.L., Tasca, C,I., 2012. Acute atorvastatin treatment exerts antidepressant-like effect in mice via the l-arginine-nitric oxide-cyclic guanosine monophosphate pathway and increases BDNF levels. Eur. Neuropsychopharmacol. (\u3008http:\/\/dx.doi.org\/10.1016\/j.euroneuro.2012.05.005\u3009)","DOI":"10.1016\/j.euroneuro.2012.05.005"},{"key":"10.1016\/j.brainres.2013.03.029_bib28","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.bbr.2012.08.017","article-title":"Neuroprotective effects of agmatine in mice infused with a single intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)","volume":"235","author":"Matheus","year":"2012","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainres.2013.03.029_bib29","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","article-title":"Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains","volume":"38","author":"McGeer","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.brainres.2013.03.029_bib30","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0361-9230(02)00754-2","article-title":"Impaired learning in a spatial working memory version and in a cued version of the water maze in rats with MPTP-induced mesencephalic dopaminergic lesions","volume":"58","author":"Miyoshi","year":"2002","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.brainres.2013.03.029_bib31","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0304-3940(94)90508-8","article-title":"Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from parkinsonian patients","volume":"180","author":"Mogi","year":"1994","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainres.2013.03.029_bib32","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1007\/s00702-010-0464-x","article-title":"Proanthocyanidin-rich fraction from Croton celtidifolius Baill confers neuroprotection in the intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine rat model of Parkinson's disease","volume":"117","author":"Moreira","year":"2010","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.brainres.2013.03.029_bib33","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/297681a0","article-title":"Place navigation impaired in rats with hippocampal lesions","volume":"297","author":"Morris","year":"1982","journal-title":"Nature"},{"key":"10.1016\/j.brainres.2013.03.029_bib34","first-page":"143","article-title":"Cytokines in Parkinson's disease","volume":"58","author":"Nagatsu","year":"2000","journal-title":"J. Neural Transm. Suppl."},{"key":"10.1016\/j.brainres.2013.03.029_bib35","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.expneurol.2010.08.030","article-title":"Atorvastatin prevents hippocampal cell death, neuroinflammation and oxidative stress following amyloid-\u03b2(1-40) administration in mice: evidence for dissociation between cognitive deficits and neuronal damage","volume":"226","author":"Piermartiri","year":"2010","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.brainres.2013.03.029_bib36","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s12640-009-9057-6","article-title":"Atorvastatin prevents hippocampal cell death due to quinolinic acid-induced seizures in mice by increasing Akt phosphorylation and glutamate uptake","volume":"16","author":"Piermartiri","year":"2009","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.brainres.2013.03.029_bib37","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/266730a0","article-title":"Depression: a new animal model sensitive to antidepressant treatments","volume":"266","author":"Porsolt","year":"1977","journal-title":"Nature"},{"key":"10.1016\/j.brainres.2013.03.029_bib38","doi-asserted-by":"crossref","first-page":"489","DOI":"10.2174\/138161211795164095","article-title":"The intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a new rodent model to test palliative and neuroprotective agents for Parkinson's disease","volume":"17","author":"Prediger","year":"2011","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.brainres.2013.03.029_bib39","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s12640-009-9087-0","article-title":"Single intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57BL\/6 mice models early preclinical phase of Parkinson's disease","volume":"2","author":"Prediger","year":"2010","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.brainres.2013.03.029_bib40","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.expneurol.2006.07.001","article-title":"The risk is in the air: Intranasal administration of MPTP to rats reproducing clinical features of Parkinson's disease","volume":"202","author":"Prediger","year":"2006","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.brainres.2013.03.029_bib41","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.bbr.2003.11.009","article-title":"Facilitation of short-term social memory by ethanol in rats is mediated by dopaminergic receptors","volume":"153","author":"Prediger","year":"2004","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainres.2013.03.029_bib42","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/01.fbp.0000166825.62130.9a","article-title":"Antagonistic interaction between adenosine A2A and dopamine D2 receptors modulates the social recognition memory in reserpine-treated rats","volume":"16","author":"Prediger","year":"2005","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.brainres.2013.03.029_bib43","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1749-6632.2009.03885.x","article-title":"Risk is in the air: an intranasal MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) rat model of Parkinson's disease","volume":"1170","author":"Prediger","year":"2009","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.brainres.2013.03.029_bib44","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1046\/j.1471-4159.2001.00183.x","article-title":"The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a technical review of its utility and safety","volume":"76","author":"Przedborski","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2013.03.029_bib45","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1002\/mds.23102","article-title":"Statin use and Parkinson's disease in Denmark","volume":"25","author":"Ritz","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.brainres.2013.03.029_bib46","doi-asserted-by":"crossref","first-page":"13898","DOI":"10.1074\/jbc.M209164200","article-title":"Nerve growth factor protects against 6-hydroxydopamine-induced oxidative stress by increasing expression of heme oxygenase-1 in a phosphatidylinositol 3-kinase-dependent manner","volume":"278","author":"Salinas","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.brainres.2013.03.029_bib47","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.pnpbp.2010.06.004","article-title":"Depressive-like behaviors alterations induced by intranigral MPTP, 6-OHDA, LPS and rotenone models of Parkinson's disease are predominantly associated with serotonin and dopamine","volume":"34","author":"Santiago","year":"2010","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.brainres.2013.03.029_bib48","doi-asserted-by":"crossref","DOI":"10.1037\/0735-7044.98.5.908","article-title":"Chemosensory and hormonal mediation of social memory in male rats","volume":"98,","author":"Sawyer","year":"1984","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.brainres.2013.03.029_bib49","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1023\/A:1001958023096","article-title":"MPTP susceptibility in the mouse: behavioral, neurochemical, and histological analysis of gender and strain differences","volume":"30","author":"Sedelis","year":"2000","journal-title":"Behav. Genet."},{"key":"10.1016\/j.brainres.2013.03.029_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2004.02.083","article-title":"Simvastatin prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced striatal dopamine depletion and protein tyrosine nitration in mice","volume":"1037","author":"Selley","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2013.03.029_bib51","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/1097-4547(20010301)63:5<402::AID-JNR1035>3.0.CO;2-F","article-title":"Nerve growth factor prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced cell death via the Akt pathway by suppressing caspase-3-like activity using PC12 cells: relevance to therapeutical application for Parkinson's disease","volume":"63","author":"Shimoke","year":"2001","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.brainres.2013.03.029_bib52","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s00213-006-0630-x","article-title":"Evaluation of reward processes in an animal model of depression","volume":"190","author":"Slattery","year":"2007","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.brainres.2013.03.029_bib53","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1096\/fj.02-0216fje","article-title":"Mice deficient in TNF receptors are protected against dopaminergic neurotoxicity: implications for Parkinson's disease","volume":"16","author":"Sriram","year":"2002","journal-title":"FASEB J."},{"key":"10.1016\/j.brainres.2013.03.029_bib54","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.neuroscience.2008.08.035","article-title":"Emotional, cognitive and neurochemical alterations in a premotor stage model of Parkinson's disease","volume":"156","author":"Tadaiesky","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainres.2013.03.029_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbr.2010.03.004","article-title":"Behavioral phenotyping of mouse models of Parkinson's disease","volume":"211","author":"Taylor","year":"2010","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainres.2013.03.029_bib56","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.parkreldis.2007.06.007","article-title":"The premotor phase of Parkinson's disease","volume":"13","author":"Tolosa","year":"2007","journal-title":"Parkinsonism. Relat. Disord."},{"key":"10.1016\/j.brainres.2013.03.029_bib57","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.neulet.2008.09.001","article-title":"Frequency of climbing behavior as a predictor of altered motor activity in rat forced swimming test","volume":"445","author":"Vieira","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainres.2013.03.029_bib58","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1212\/01.wnl.0000286942.14552.51","article-title":"Statin use and the risk of Parkinson disease","volume":"70","author":"Wahner","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.brainres.2013.03.029_bib59","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.bbr.2009.11.006","article-title":"Involvement of NMDA receptors in both MPTP-induced neuroinflammation and deficits in episodic-like memory in Wistar rats","volume":"208","author":"Wang","year":"2010","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainres.2013.03.029_bib60","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.expneurol.2010.04.006","article-title":"Statins: multiple neuroprotective mechanisms in neurodegenerative diseases","volume":"230","author":"Wang","year":"2011","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.brainres.2013.03.029_bib61","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1037\/a0017401","article-title":"MPTP lesion causes neuroinflammation and deficits in object recognition in Wistar rats","volume":"123","author":"Wang","year":"2009","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.brainres.2013.03.029_bib62","first-page":"20","article-title":"Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease","volume":"5","author":"Wolozin","year":"2007","journal-title":"B.M.C. Med."},{"key":"10.1016\/j.brainres.2013.03.029_bib63","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1749-6632.2009.05359.x","article-title":"Statins and neuroprotection: a prescription to move the field forward","volume":"1199","author":"Wood","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.brainres.2013.03.029_bib64","doi-asserted-by":"crossref","first-page":"e20945","DOI":"10.1371\/journal.pone.0020945","article-title":"Simvastatin prevents dopaminergic neurodegeneration in experimental parkinsonian models: the association with anti-inflammatory responses","volume":"6","author":"Yan","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.brainres.2013.03.029_bib65","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/S0735-1097(03)00785-X","article-title":"Long-term statin use and psychological well-being","volume":"42","author":"Young-Xu","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.brainres.2013.03.029_bib66","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/00146965-200312000-00001","article-title":"A review of the cognitive and behavioral sequelae of Parkinson's disease: relationship to frontostriatal circuitry","volume":"16","author":"Zgaljardic","year":"2003","journal-title":"Cogn. Behav. Neurol."}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899313004514?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899313004514?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T08:50:38Z","timestamp":1565599838000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899313004514"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":66,"alternative-id":["S0006899313004514"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2013.03.029","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}